U.S. flag

An official website of the United States government

NM_000026.4(ADSL):c.1277G>A (p.Arg426His) AND Inborn genetic diseases

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 2, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002512680.2

Allele description [Variation Report for NM_000026.4(ADSL):c.1277G>A (p.Arg426His)]

NM_000026.4(ADSL):c.1277G>A (p.Arg426His)

Gene:
ADSL:adenylosuccinate lyase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q13.1
Genomic location:
Preferred name:
NM_000026.4(ADSL):c.1277G>A (p.Arg426His)
Other names:
p.R426H:CGT>CAT
HGVS:
  • NC_000022.11:g.40364965G>A
  • NG_007993.2:g.23466G>A
  • NM_000026.4:c.1277G>AMANE SELECT
  • NM_001123378.3:c.1191+600G>A
  • NM_001317923.2:c.1085G>A
  • NM_001363840.3:c.1277G>A
  • NP_000017.1:p.Arg426His
  • NP_001304852.1:p.Arg362His
  • NP_001350769.1:p.Arg426His
  • NC_000022.10:g.40760969G>A
  • NM_000026.2:c.1277G>A
  • NM_000026.3:c.1277G>A
  • NR_134256.2:n.1367G>A
  • P30566:p.Arg426His
Protein change:
R362H; ARG426HIS
Links:
UniProtKB: P30566#VAR_007978; OMIM: 608222.0002; dbSNP: rs119450941
NCBI 1000 Genomes Browser:
rs119450941
Molecular consequence:
  • NM_001123378.3:c.1191+600G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000026.4:c.1277G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001317923.2:c.1085G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001363840.3:c.1277G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_134256.2:n.1367G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003677029Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Aug 2, 2021)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Human adenylosuccinate lyase (ADSL), cloning and characterization of full-length cDNA and its isoform, gene structure and molecular basis for ADSL deficiency in six patients.

Kmoch S, Hartmannová H, Stibůrková B, Krijt J, Zikánová M, Sebesta I.

Hum Mol Genet. 2000 Jun 12;9(10):1501-13.

PubMed [citation]
PMID:
10888601

Biochemical and structural analysis of 14 mutant adsl enzyme complexes and correlation to phenotypic heterogeneity of adenylosuccinate lyase deficiency.

Zikanova M, Skopova V, Hnizda A, Krijt J, Kmoch S.

Hum Mutat. 2010 Apr;31(4):445-55. doi: 10.1002/humu.21212.

PubMed [citation]
PMID:
20127976
See all PubMed Citations (7)

Details of each submission

From Ambry Genetics, SCV003677029.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

The c.1277G>A (p.R426H) alteration is located in exon 12 (coding exon 12) of the ADSL gene. This alteration results from a G to A substitution at nucleotide position 1277, causing the arginine (R) at amino acid position 426 to be replaced by a histidine (H). Based on data from the Genome Aggregation Database (gnomAD), the ADSL c.1277G>A alteration was observed in 0.02% (51/282896) of total alleles studied, with a frequency of 0.03% (42/129196) in the European (non-Finnish) subpopulation. This mutation is the most common mutation occurring in about 30% of affected individuals; it has been identified in the homozygous and compound heterozygous state in multiple individuals with adenylosuccinase deficiency (Ray, 2013; Jurecka, 2014; Donti, 2016; Mastrogiorgio, 2021). In vitro analysis demonstrated reduced thermal stability and ADSL activity (Kmoch, 2000; Zikanova, 2010). The p.R426H alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024